6.340NOK-0.47%Mkt Cap: 214.37M $P/E: —Today
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 200…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap214.37M $
Enterprise Value209.98M $
Revenue (TTM)78.43K $
Gross Profit78.43K $
Net Income (TTM)-5.42M $
Revenue/Share0.0003 USD
Last Price6.340 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees18
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0010597883
Valuation
P/E (Trailing)—
P/E (Forward)-59.55
PEG—
EV/EBITDA-44.81
EV/Revenue2677.35
P/S2810.50
P/B5.09
EPS (TTM)-0.17
EPS (Forward)-0.11
52W Range
2.51597% of range6.450
52W High6.450 NOK
52W Low2.515 NOK
Profitability
Gross Margin100.00%
Oper. Margin-4932.75%
EBITDA Margin0.00%
Profit Margin-14500.00%
ROE-12.72%
ROA-8.19%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.44M $
CapEx (TTM)6.83M $
FCF Margin-10787.05%
FCF Yield-3.95%
Net Debt-857.85K $
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity0.38
Current Ratio4.57
Quick Ratio4.46
Book Value/Sh1.288 NOK
Cash/Share0.5100 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.500 NOK
Upside (mean)-44.8%
Target Range3.500 NOK – 3.500 NOK
# Analysts1
Ownership
Shares Out.360.00M
Float148.82M
Insiders41.21%
Institutions8.83%
Technical
SMA 504.708 (+34.7%)
SMA 2004.578 (+38.5%)
Beta-0.23
S&P 52W Chg18.16%
Avg Vol (30d)3.95M
Avg Vol (10d)5.36M
Technical Indicators
RSI (14)68.8
MACD0.4198
MACD Signal0.3798
MACD Hist.+0.0400
BB Upper6.759 NOK
BB Middle5.388 NOK
BB Lower4.018 NOK
BB Width50.85%
ATR (14)0.3126 NOK
Vol Ratio (20d)2.14x